deferoxamine has been researched along with transforming growth factor beta in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, BL; Firth, JD; Gleadle, JM; Ratcliffe, PJ | 1 |
| Liu, Y; Parkes, JG; Sirna, JB; Templeton, DM | 1 |
| Clark, IM; Garcia, PL; Norman, JT | 1 |
| Cho, H; Kim, HJ; Lee, JH; Lim, IK; Yoon, G; Yoon, YS | 1 |
| Churg, A; Dai, J; Vincent, R; Xie, C | 1 |
| Aizawa, T; Ishizaka, N; Iso-o, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M | 1 |
| Hara, M; Ishizaka, N; Matsuzaki, G; Mori, I; Nagai, R; Ohno, M; Saito, K; Sata, M | 1 |
| Chung, HY; Jou, MJ; Lim, IK; Malka, F; Martinou, JC; Rojo, M; Yoon, DS; Yoon, G; Yoon, SH; Yoon, YS | 1 |
| Dai, KR; Qu, ZH; Tang, TT; Zhang, XL | 1 |
| Chu, GT; Eberhardt, A; Gilbert, S; Goldstein, J; Stewart, R | 1 |
| Al-Harbi, MM; Al-Rejaie, SS; Al-Shabanah, OA; Al-Yahya, AA; Aleisa, AM; Bakheet, SA; Hafez, MM; Sayed-Ahmed, MM | 1 |
| Boesch-Saadatmandi, C; Ciesla, M; Dulak, J; Jozkowicz, A; Kozakowska, M; Loboda, A; Rimbach, G; Stachurska, A; Wolffram, S | 1 |
| Banfi, C; Cappellini, MD; Criniti, S; Gelosa, P; Gianazza, E; Guerrini, U; Pignieri, A; Sironi, L; Tremoli, E | 1 |
| Horinouchi, Y; Ikeda, Y; Imao, M; Ishizawa, K; Izawa-Ishizawa, Y; Kihira, Y; Miyamoto, L; Ozono, I; Tajima, S; Tamaki, T; Tsuchiya, K | 1 |
| Brazda, N; Estrada, V; Faissner, A; König, B; Krafft, S; Müller, HW; Vogelaar, CF; Ziegler, B | 1 |
| He, K; Liu, P; Ma, Z; Song, H; Xu, LX; Yin, W | 1 |
| Cheon, YI; Kim, HS; Kim, JM; Lee, BJ; Lee, JC; Lee, M; Park, GC; Shin, SC; Sung, ES | 1 |
17 other study(ies) available for deferoxamine and transforming growth factor beta
| Article | Year |
|---|---|
Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.
Topics: Angiogenesis Inducing Agents; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line; Chelating Agents; Cobalt; Deferoxamine; Endothelial Growth Factors; Erythropoietin; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Liver Neoplasms; Lymphokines; Molecular Sequence Data; Neovascularization, Pathologic; Placenta Growth Factor; Platelet-Derived Growth Factor; Pregnancy Proteins; RNA, Messenger; RNA, Small Nuclear; Transforming Growth Factor beta; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1995 |
Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts.
Topics: Animals; Animals, Newborn; Cells, Cultured; Chelation Therapy; Collagen; Culture Media, Conditioned; Deferoxamine; Disease Progression; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart; Iron; Iron Chelating Agents; Iron Overload; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Lung; Mink; Muscle Proteins; Myocardium; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Regulatory Sequences, Nucleic Acid; RNA-Binding Proteins; RNA, Messenger; Transforming Growth Factor beta; Treatment Failure | 2000 |
Hypoxia promotes fibrogenesis in human renal fibroblasts.
Topics: Actins; Antimutagenic Agents; Cell Division; Cell Hypoxia; Cell Size; Cell Survival; Cells, Cultured; Chelating Agents; Cobalt; Collagen; Collagenases; Culture Media, Conditioned; Deferoxamine; Extracellular Matrix; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Hypoxia; Kidney Cortex; Kidney Failure, Chronic; Oxygen; Promoter Regions, Genetic; Protein Kinase C; Protein-Tyrosine Kinases; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Transcription, Genetic; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.
Topics: Animals; beta-Galactosidase; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p27; Deferoxamine; G1 Phase; Genes, Tumor Suppressor; Hepatocytes; Iron Chelating Agents; Poly(ADP-ribose) Polymerases; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Tumor Suppressor Proteins | 2002 |
Air pollution particles produce airway wall remodeling in rat tracheal explants.
Topics: Air Pollution; alpha-Fetoproteins; Animals; Cells, Cultured; Chelating Agents; Collagen; Deferoxamine; DNA, Complementary; Enzyme Inhibitors; Fibrosis; Flavonoids; Gene Expression Regulation; Hydroxyproline; Imidazoles; Iron; Mitogen-Activated Protein Kinases; NF-kappa B; Organ Culture Techniques; Oxidants; p38 Mitogen-Activated Protein Kinases; Peptides; Procollagen; Promoter Regions, Genetic; Pyridines; Rats; Thiourea; Time Factors; Trachea; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.
Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents | 2005 |
Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II.
Topics: Angiotensin II; Animals; Deferoxamine; Fatty Acid Synthases; Gene Expression Regulation; In Situ Hybridization; Iron; Iron Chelating Agents; Kidney; Lipid Metabolism; Lipids; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staining and Labeling; Sterol Regulatory Element Binding Protein 1; Superoxides; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2005 |
Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1.
Topics: Animals; Cells, Cultured; Cellular Senescence; Child; Deferoxamine; DNA, Mitochondrial; Ethidium; Fibroblasts; Gene Expression; Humans; Hydrogen Peroxide; Iron Chelating Agents; Male; Membrane Fusion; Membrane Proteins; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Phenotype; Recombinant Fusion Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Promotion of osteogenesis through beta-catenin signaling by desferrioxamine.
Topics: Alkaline Phosphatase; Animals; beta Catenin; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Cell Differentiation; Cells, Cultured; Deferoxamine; Humans; Mesenchymal Stem Cells; Mice; Osteoblasts; Osteogenesis; Pluripotent Stem Cells; RNA Interference; Siderophores; Signal Transduction; Transforming Growth Factor beta | 2008 |
Increasing vascularity to improve healing of a segmental defect of the rat femur.
Topics: Angiogenesis Inducing Agents; Animals; Bone Morphogenetic Protein 2; Deferoxamine; Dose-Response Relationship, Drug; Femoral Fractures; Fracture Healing; Neovascularization, Physiologic; Polypharmacy; Radiography; Rats; Recombinant Proteins; Transforming Growth Factor beta; Treatment Outcome | 2011 |
Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-β/Smad p53 pathway in rat model.
Topics: Animals; Cardiotoxins; Deferoxamine; Disease Models, Animal; Doxorubicin; Gene Expression Regulation; Heart Diseases; Isoenzymes; Male; Rats; Rats, Wistar; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2012 |
Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Deferoxamine; Epithelial Cells; Erythropoietin; Gene Expression Regulation; Heme Oxygenase-1; Kidney Tubules, Proximal; MicroRNAs; NF-E2-Related Factor 2; Ochratoxins; Reactive Oxygen Species; Signal Transduction; Swine; Transforming Growth Factor beta | 2013 |
Altered iron homeostasis in an animal model of hypertensive nephropathy: stroke-prone rats.
Topics: Animals; Blood Pressure; Deferoxamine; Disease Models, Animal; Hemolysis; Homeostasis; Hypertension, Renal; Iron; Kidney; Male; Models, Animal; Nephritis; Oxidative Stress; Proteinuria; Proteomics; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Sodium Chloride, Dietary; Stroke; Transforming Growth Factor beta | 2013 |
Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
Topics: Animals; Blotting, Western; Chelation Therapy; Deferoxamine; Fibrosis; Immunohistochemistry; Iron Chelating Agents; Kidney Diseases; Mice; Signal Transduction; Transforming Growth Factor beta; Ureteral Obstruction | 2014 |
Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In Vivo.
Topics: Animals; Astrocytes; Axons; Central Nervous System; Cicatrix; Collagen Type IV; Cyclic AMP; Deferoxamine; Disease Models, Animal; Female; Fibroblasts; Humans; In Vitro Techniques; Iron Chelating Agents; Nerve Regeneration; Neurites; Rats; Rats, Wistar; RNA, Messenger; Spinal Cord Injuries; Transforming Growth Factor beta | 2015 |
Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling.
Topics: Cell Line, Tumor; Cell Movement; Deferoxamine; Epithelial Cells; Female; Gene Expression; Humans; Iron; Iron Chelating Agents; Mammary Glands, Human; NF-kappa B; Organ Specificity; Signal Transduction; Smad2 Protein; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2016 |
Effect of deferoxamine and ferrostatin-1 on salivary gland dysfunction in ovariectomized rats.
Topics: Animals; Deferoxamine; Female; Fibrosis; Iron; Rats; Rats, Sprague-Dawley; Salivary Glands; Transforming Growth Factor beta; Xerostomia | 2023 |